喜保宁容易出现的不良反应有哪些？

Vigabatrin, also known as vigabatrin tablets, with the trade name Sabril, is a drug for treating infantile spasms and epilepsy. It was developed in 1980 and was approved for marketing by the British Food and Drug Administration in 1989. In August 2009, the U.S. Food and Drug Administration approved the marketing of Vigabatrin in the United States to treat spasticity in children aged 1 month to 2 years old. For such patients, this is undoubtedly great news. So, what are the possible adverse reactions of this drug? Let’s take a look together!

What are the common adverse reactions of Vigabatrin?

Side effects that may occur in patients treated with Vigabatrin include depression, confusion, dizziness, headache, drowsiness, fatigue, etc.

Occasional aggressive behavior and psychosis (more common in patients with a history of psychosis and behavioral problems), alopecia, edema, gastrointestinal disturbances, weight gain, diplopia, and memory loss.

Sometimes, tremor, paresthesia, ataxia, irritability, nervousness, nystagmus, etc. may occur. Some patients may develop irreversible visual field loss, retinal lesions such as peripheral retinal atrophy, and more rarely, optic neuritis and atrophy.

Mentally, agitation, aggressive behavior, and paranoia may occur in people with or without a history of mental illness. Mania or mental disorder may rarely occur. Hemoglobin and transaminase values may be reduced, and children may be excited and anxious.

Therefore, you need to pay attention when the above situation occurs. If it is a serious side effect, please go to hospital for treatment immediately! If you need to purchase Vigabatrin, please contact the Medical Companion Travel Service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.